- Global Pharma News & Resources

Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market to 2030 - by Category, Service Type, Therapeutic Application, End-user and Region -

DUBLIN--(BUSINESS WIRE)--The "Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Region" report has been added to's offering.

The Global pharmaceutical CDMO market will reach $289.2 billion by 2030, growing by 6.9% annually over 2020-2030 driven by increasing demand for biological therapies and specialty medicines, rising demand for cost control in drug development, and rising healthcare expenditures.

Highlighted with 96 tables and 86 figures, this 194-page report is based on comprehensive research of the entire global pharmaceutical CDMO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year.

Key Players:

Company Profiles of CMO:

  • Aenova Group
  • Baxter BioPharma Solutions
  • Boehringer Ingelheim
  • Catalent Inc.
  • Famar S.A.
  • Hospira, Inc.
  • Jubilant Life Sciences Ltd.
  • Lonza Group
  • Patheon Inc.
  • Pfizer CentreSource
  • Recipharm AB
  • Vetter Pharma International GmbH

Company Profiles of CRO:

  • Charles River Laboratories
  • CMIC Co. Ltd
  • Covance Inc.
  • Hangzhou Tigermed Consulting Co Ltd
  • ICON Plc
  • IQVIA Holdings Inc.
  • LSK Global Pharma Service Co Ltd
  • Novotech Pty Ltd
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC (PPD)
  • PRA Health Sciences Inc.
  • Quanticate Ltd
  • Samsung Bioepis Co. Ltd
  • SGS SA (SGS Life Sciences)
  • Syneos Health Inc.
  • WuXi AppTec Inc.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter's Fiver Forces

The trend and outlook of the global market is forecast in an optimistic, balanced, and conservative view by taking into account the COVID-19 pandemic. The balanced (most likely) projection is used to quantify global pharmaceutical CDMO market in every aspect of the classification from perspectives of Category, Service Type, Therapeutic Application, End User, and Region.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter's Fiver Forces Analysis

3 Segmentation of Global Market by Category

3.1 Market Overview by Category

3.2 Pharmaceutical Industry

3.3 Biopharmaceutical Industry

4 Segmentation of Global Market by Service Type

4.1 Market Overview by Service Type

4.2 Pharmaceutical Contract Manufacturing Organization (CMO)

4.2.1 Active Pharmaceutical Ingredients (API)

4.2.2 Finished Dosage Formulations (FDF)

4.2.3 Secondary Packaging

4.3 Pharmaceutical Contract Research Organization (CRO)

4.3.1 CRO for Pre-clinical Development

4.3.2 CRO for Phase I Trials

4.3.3 CRO for Phase II Trials

4.3.4 CRO for Phase III Trials

4.3.5 CRO for Phase IV Trials

4.3.6 Laboratory Services

4.3.7 Consulting Services

4.3.8 Data Management Services

5 Segmentation of Global Market by Therapeutic Application

5.1 Market Overview by Therapeutic Application

5.2 Infectious Diseases

5.3 Oncology

5.4 Metabolic Disorders

5.5 Cardiovascular Disorders

5.6 Central Nervous System

5.7 Pulmonary Disorders

5.8 Gastrointestinal Disorders

5.9 Other Therapeutic Applications

6 Segmentation of Global Market by End User

6.1 Market Overview by End User

6.2 Pharmaceutical & Biopharmaceutical Companies

6.3 Medical Device Companies

6.4 Academic Institutes

7 Segmentation of Global Market by Region

7.1 Geographic Market Overview 2019-2030

7.2 North America Market 2019-2030 by Country

7.3 European Market 2019-2030 by Country

7.4 Asia-Pacific Market 2019-2030 by Country

7.5 South America Market 2019-2030 by Country

7.6 MEA Market 2019-2030 by Country

8 Competitive Landscape

8.1 Overview of Key Vendors

8.2 New Product Launch, Partnership, Investment, and M&A

8.3 Company Profiles

9 Investing in Global Market: Risk Assessment and Management

9.1 Risk Evaluation of Global Market

9.2 Critical Success Factors (CSFs)

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 08-Jan-2021